Abstract: |
Abnormalities of chromosome 1q21 are common in B cell malignancies, but their target genes are largely unknown. By cloning the breakpoints of a (1;14) (q21;q32) chromosomal translocation in a myeloma cell line, we have identified two novel genes, IRTA1 and IRTA2, encoding cell surface receptors homologous to the Fc and inhibitory receptor families. Both genes are selectively expressed in mature B cells: IRTA1 in marginal zone B cells and IRTA2 in centrocytes, marginal zone B cells, and immunoblasts. As a result of the t(1;14), IRTA1 is fused to the immunoglobulin Cα domain to produce a chimeric IRTA1/Cα fusion protein. In tumor cell lines with 1q21 abnormalities, IRTA2 expression is deregulated. Thus, IRTA1 and IRTA2 are novel immunoreceptors implicated in B cell development and lymphomagenesis. |
Keywords: |
controlled study; protein expression; human cell; exons; multiple myeloma; gene expression profiling; cell maturation; introns; tumor cells, cultured; b lymphocyte; b-lymphocytes; chimera; molecular cloning; cloning, molecular; b cell lymphoma; gene expression regulation, neoplastic; lymphoma, b-cell; amino acid sequence; molecular sequence data; rna, messenger; oncogene proteins, fusion; chromosome breakage; chromosome translocation; base sequence; translocation, genetic; protein structure, tertiary; chromosomes, human, pair 1; chromosome 1q; germ-line mutation; multigene family; immunoglobulins; cell surface receptor; receptors, cell surface; immunoglobulin receptor; receptors, fc; myeloma proteins; chromosomes, human, pair 14; immunoglobulin fc fragment; humans; human; priority journal; article; immunoblast
|